c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells
Natesan Sankar, Ravi-Kumar Kadeppagari, Bayar Thimmapaya, Natesan Sankar, Ravi-Kumar Kadeppagari, Bayar Thimmapaya
Abstract
We previously showed that in quiescent cells, p300/CBP (CREB-binding protein)family coactivators repress c-myc and prevent premature induction of DNA synthesis. p300/CBP-depleted cells exit G(1) early and continue to accumulate in S phase but do not progress into G(2)/M, and eventually they die of apoptosis. Here, we show that the S-phase arrest in these cells is because of an intra-S-phase block. The inappropriate DNA synthesis that occurs as a result of forced expression of c-myc leads to the activation of the DNA damage response as evidenced by the phosphorylation of several checkpoint related proteins and the formation of foci containing gamma-H2AX. The activation of checkpoint response is related to the induction of c-myc, as the phosphorylation of checkpoint proteins can be reversed when cells are treated with a c-Myc inhibitor or when Myc synthesis is blocked by short hairpin RNA. Using the DNA fiber assay, we show that in p300-depleted cells initiation of replication occurs from multiple replication origins. Chromatin loading of the Cdc45 protein also indicates increased origin activity in p300 knockdown cells. Immunofluorescence experiments indicate that c-Myc colocalizes with replication foci, consistent with the recently reported direct role of c-Myc in the initiation of DNA synthesis. Thus, the inappropriate S-phase entry of p300 down-regulated cells is likely to be because of c-Myc-induced deregulated replication origin activity, which results in replicative stress, activation of a DNA damage response, and S-phase arrest. Our results point to an important role for p300 in maintaining genomic integrity by negatively regulating c-myc.
Figures
![FIGURE 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700001.jpg)
![FIGURE 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700002.jpg)
![FIGURE 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700003.jpg)
![FIGURE 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700004.jpg)
![FIGURE 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700005.jpg)
![FIGURE 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700006.jpg)
![FIGURE 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2685700/bin/zbc0260977700007.jpg)
Source: PubMed